BioMarin Pharmaceutical (NASDAQ:BMRN)‘s stock had its “positive” rating reaffirmed by analysts at Wells Fargo & Co. in a research report issued to clients and investors on Tuesday, StockRatingsNetwork.com reports. Shares of BioMarin Pharmaceutical (NASDAQ:BMRN) remained flat at $66.91 during trading on Tuesday. BioMarin Pharmaceutical has a one year low of $46.53 and a one year […]
Wells Fargo & Co. Reiterates “Positive” Rating for BioMarin Pharmaceutical (BMRN) is a post from: Zolmax